Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04018638Not ApplicableActive Not Recruiting

Blood-Flow Restriction Exercise Following a Knee Replacement

Role: lead

NCT03626363Not ApplicableCompleted

Mindfulness and Neural Cardiovascular Control in Humans

Role: lead

NCT04992702Not ApplicableCompleted

Effect of Animated Video on Comprehension and Implementation Feasibility

Role: lead

NCT04613609Early Phase 1Completed

Vaporized Nicotine and Autonomic Control

Role: lead

NCT01554527Not ApplicableCompleted

Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children

Role: collaborator

NCT01568736Withdrawn

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency

Role: lead

All 6 trials loaded